terry hallinan, thanks for your reply. I think techisbest knows the answer and that's why he doesn't reply. There are many small biotech companies out there quietly doing their research and just PR research results when appropriate. BIPH is really overboard on the paid hype, and there is only one reason for that, to sell shares. The filing will tell the true story, IMO. This doesn't grate on all "longs" since they know the score and are busy trading the stock. GLTY.
"The promotion grates on every long and may or may not be greatly overdone but without promotion there would be no research and no Biophan at all."